{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:22:23Z","timestamp":1790544143007,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00277-022-04906-8","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T22:02:27Z","timestamp":1656799347000},"page":"2053-2067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients"],"prefix":"10.1007","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-2562","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Pi\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rodr\u00edguez-Belenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Lopez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jos\u00e9","family":"Terol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Calabuig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Sanz-Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Marin-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Montoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Facal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jes\u00fas","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rodriguez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T.","family":"Olave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Cascales-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-\u00c1ngel","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Villalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rold\u00e1n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ribes-Amoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Gonz\u00e1lez-Santillana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Garcia-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Serrano-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Cedillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Soria-Olivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"issue":"9","key":"4906_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-020-00177-z","volume":"25","author":"JL Pi\u00f1ana","year":"2020","unstructured":"Pi\u00f1ana JL, Martino R, Garc\u00eda-Garc\u00eda I, Parody R, Morales MD, Benzo G et al (2020 Aug) Infectious complications subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH). Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol 25(9):21. https:\/\/doi.org\/10.1186\/s40164-020-00177-z","journal-title":"Exp Hematol Oncol"},{"key":"4906_CR2","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Su\u00e1rez J, de la Cruz J, Cedillo \u00c1, Llamas P, Duarte R, Jim\u00e9nez-Yuste V, et al (2020) Asociaci\u00f3n Madrile\u00f1a de Hematolog\u00eda y Hemoterapia (AMHH). Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. Oct 8;13(1):133. https:\/\/doi.org\/10.1186\/s13045-020-00970-7","DOI":"10.1186\/s13045-020-00970-7"},{"key":"4906_CR3","doi-asserted-by":"publisher","unstructured":"Pagano L, Salmanton-Garc\u00eda J, Marchesi F, Busca A, Corradini P, Hoenigl M, et al (2021) EPICOVIDEHA working group. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. Oct 14;14(1):168. https:\/\/doi.org\/10.1186\/s13045-021-01177-0","DOI":"10.1186\/s13045-021-01177-0"},{"key":"4906_CR4","doi-asserted-by":"crossref","unstructured":"Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, et al. (2021) Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. Jan 19:S2352-3026(20)30429-4.","DOI":"10.1016\/S2352-3026(20)30429-4"},{"key":"4906_CR5","doi-asserted-by":"publisher","unstructured":"Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, et al. (2021) COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. Jun 2:1\u201310. https:\/\/doi.org\/10.1038\/s41375-021-01302-5. Epub ahead of print. PMID: 34079042; PMCID: PMC8171362.","DOI":"10.1038\/s41375-021-01302-5"},{"issue":"10","key":"4906_CR6","doi-asserted-by":"publisher","first-page":"e801","DOI":"10.1016\/j.clml.2021.06.024","volume":"21","author":"JM Ribera","year":"2021","unstructured":"Ribera JM, Morgades M, Coll R, Barba P, L\u00f3pez-Lorenzo JL, Montesinos P et al (2021 Oct) Frequency, clinical characteristics and outcome of adults with acute lymphoblastic leukemia and COVID 19 infection in the first vs. second pandemic wave in Spain. Clin Lymphoma Myeloma Leuk 21(10):e801\u2013e809. https:\/\/doi.org\/10.1016\/j.clml.2021.06.024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4906_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2021.1992619","volume":"20","author":"JL Pi\u00f1ana","year":"2021","unstructured":"Pi\u00f1ana JL, V\u00e1zquez L, Martino R, de la C\u00e1mara R, Sureda A, Rodr\u00edguez-Veiga R et al (2021 Oct) Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. Leuk Lymphoma 20:1\u201313. https:\/\/doi.org\/10.1080\/10428194.2021.1992619","journal-title":"Leuk Lymphoma"},{"key":"4906_CR8","unstructured":"European Society for Medical Oncology. ESMO statements for vaccination against COVID-19 in patients with cancer. https:\/\/www.esmo.org\/covid-19-and-cancer\/covid-19-vaccination (accessed Jan 7, 2021)."},{"key":"4906_CR9","unstructured":"Auletta J, Chemaly R, Khawaja F, Papanicolau G, Hill J, Kanter J (2021) ASH-ASTCT COVID-19 and vaccines: frequently asked questions.;2\u20135"},{"key":"4906_CR10","unstructured":"https:\/\/ehaweb.org\/covid-19\/eha-statement-on-covid-19-vaccines\/recommendations-for-covid-19-vaccination-in-patients-with-hematologic-cancer\/"},{"key":"4906_CR11","unstructured":"https:\/\/www.prnewswire.com\/news-releases\/nccn-shares-new-guidance-principles-for-vaccinating-people-with-cancer-against-covid-19-301213154.html."},{"key":"4906_CR12","doi-asserted-by":"publisher","unstructured":"Maneikis K, \u0160ablauskas K, Ringelevi\u010di\u016bt\u0117 U, Vaitek\u0117nait\u0117 V, \u010cekauskien\u0117 R, Kry\u017eauskait\u0117 L, et al. (2021) Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Lancet Haematol. Jul 2:S2352-3026(21)00169-1. https:\/\/doi.org\/10.1016\/S2352-3026(21)00169-1. Epub ahead of print. PMID: 34224668; PMCID: PMC8253543","DOI":"10.1016\/S2352-3026(21)00169-1"},{"key":"4906_CR13","doi-asserted-by":"publisher","unstructured":"Herzog Tzarfati K, Gutwein O, Apel A, Rahimi-Levene N, Sadovnik M, Harel L, et al. (2021) BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies. Am J Hematol. Jun 29. https:\/\/doi.org\/10.1002\/ajh.26284. Epub ahead of print.","DOI":"10.1002\/ajh.26284"},{"key":"4906_CR14","doi-asserted-by":"publisher","unstructured":"Redjoul R, Le Bouter A, Beckerich F, Fourati S, Maury S (2021) Antibody response after second BNT162b2 dose in allogeneic HSCT recipients. Lancet. Jul 24;398(10297):298-299. https:\/\/doi.org\/10.1016\/S0140-6736(21)01594-4. Epub 2021 Jul 13. PMID: 34270933; PMCID: PMC8277189.","DOI":"10.1016\/S0140-6736(21)01594-4"},{"key":"4906_CR15","doi-asserted-by":"publisher","unstructured":"Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, et al. (2021) Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. Jun 10;137(23):3165-3173. https:\/\/doi.org\/10.1182\/blood.2021011568. PMID: 33861303; PMCID: PMC8061088","DOI":"10.1182\/blood.2021011568"},{"key":"4906_CR16","doi-asserted-by":"publisher","unstructured":"Ali H, Ngo D, Aribi A, Arslan S, Dadwal S, Marcucci G, et al. (2021) Safety and tolerability of SARS-CoV-2 emergency-use authorized vaccines allogeneic hematopoietic stem cell transplant recipients. Transplant Cell Ther. Jul 15:S2666-6367(21)01073-3. https:\/\/doi.org\/10.1016\/j.jtct.2021.07.008. Epub ahead of print. PMID: 34274492; PMCID: PMC8280601","DOI":"10.1016\/j.jtct.2021.07.008"},{"issue":"8","key":"4906_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ccell.2021.07.012","volume":"39","author":"LM Greenberger","year":"2021","unstructured":"Greenberger LM, Saltzman LA, Senefeld JW, Johnson PW, DeGennaro LJ, Nichols GL (2021) Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies. Cancer Cell 39(8):1031\u20131033. https:\/\/doi.org\/10.1016\/j.ccell.2021.07.012","journal-title":"Cancer Cell"},{"key":"4906_CR18","doi-asserted-by":"publisher","unstructured":"Avivi I, Balaban R, Shragai T, Sheffer G, Morales M, Aharon A, et al. (2021) Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma. Br J Haematol. Jul 1. https:\/\/doi.org\/10.1111\/bjh.17608. Epub ahead of print","DOI":"10.1111\/bjh.17608"},{"key":"4906_CR19","doi-asserted-by":"publisher","unstructured":"Pi\u00f1ana JL, Garcia-Sanz R, Martino R, Garcia-Roa M, Martin-Martin GA, Risco-Galvez I et al. (2021) Booster effect after SARS-CoV-2 vaccination in hematological immunocompromised patients with prior COVID-19. Blood Adv. Dec 21: blood advances.2021006326.\u00a0https:\/\/doi.org\/10.1182\/bloodadvances.2021006326","DOI":"10.1182\/bloodadvances.2021006326"},{"key":"4906_CR20","doi-asserted-by":"publisher","unstructured":"Pi\u00f1ana JL, L\u00f3pez-Corral L, Martino R, Montoro J, Vazquez L, P\u00e9rez A et al (2021 Oct) Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol 25. https:\/\/doi.org\/10.1002\/ajh.26385","DOI":"10.1002\/ajh.26385"},{"key":"4906_CR21","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Monta\u00f1\u00e9s M, Rodr\u00edguez-Belenguer P, Serrano-L\u00f3pez AJ, Soria-Olivas E, Alakhdar-Mohmara Y (2020) Machine learning for mortality analysis in patients with COVID-19. Int J Environ Res Public Health. Nov 12;17(22):8386. https:\/\/doi.org\/10.3390\/ijerph17228386. PMID: 33198392; PMCID: PMC7697463","DOI":"10.3390\/ijerph17228386"},{"key":"4906_CR22","doi-asserted-by":"publisher","unstructured":"Scutari M, Denis J-B (2021) Bayesian networks: with examples in R (2nd ed.). Chapman and Hall\/CRC. https:\/\/doi.org\/10.1201\/9780429347436","DOI":"10.1201\/9780429347436"},{"key":"4906_CR23","unstructured":"Scikit-Learn: Machine learning in python. 2021. Available online: https:\/\/scikit-learn.org\/stable\/ (accessed on 01 November 2021)"},{"key":"4906_CR24","unstructured":"Pandas. 2021. Available online: https:\/\/pandas.pydata.org\/ (accessed on 01 November 2021)"},{"key":"4906_CR25","unstructured":"Numpy. 2021. Available online: https:\/\/numpy.org\/ (accessed on 01 November 2021)."},{"key":"4906_CR26","doi-asserted-by":"crossref","unstructured":"Wickham H (2016) ggplot2: elegant graphics for data analysis; Springer: New York, NY, USA","DOI":"10.1007\/978-3-319-24277-4"},{"issue":"3","key":"4906_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v035.i03","volume":"35","author":"M Scutari","year":"2010","unstructured":"Scutari M (2010) Learning Bayesian Networks with the bnlearn R Package. J Stat Softw 35(3):1\u201322. https:\/\/doi.org\/10.18637\/jss.v035.i03","journal-title":"J Stat Softw"},{"key":"4906_CR28","doi-asserted-by":"publisher","unstructured":"Stampfer SD, Goldwater MS, Jew S, Bujarski S, Regidor B, Daniely D, et al. (2021) Response to mRNA vaccination for COVID-19 among patients with multiple myeloma. Leukemia. Dec;35(12):3534-3541.\u00a0https:\/\/doi.org\/10.1038\/s41375-021-01354-7. Epub 2021 Jul 29","DOI":"10.1038\/s41375-021-01354-7"},{"issue":"11","key":"4906_CR29","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.7326\/M21-1757","volume":"174","author":"P Deepak","year":"2021","unstructured":"Deepak P, Kim W, Paley MA, Yang M, Carvidi AB, Demissie EG et al (2021 Nov) Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study. Ann Intern Med 174(11):1572\u20131585. https:\/\/doi.org\/10.7326\/M21-1757","journal-title":"Ann Intern Med"},{"issue":"16","key":"4906_CR30","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1182\/bloodadvances.2021005094","volume":"5","author":"C Perry","year":"2021","unstructured":"Perry C, Luttwak E, Balaban R, Shefer G, Morales MM, Aharon A et al (2021) Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma. Blood Adv 5(16):3053\u20133061. https:\/\/doi.org\/10.1182\/bloodadvances.2021005094","journal-title":"Blood Adv"},{"issue":"9","key":"4906_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.2021012443","volume":"138","author":"P Ghione","year":"2021","unstructured":"Ghione P, Gu JJ, Attwood K, Torka P, Goel S, Sundaram S et al (2021 Sep) Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies. Blood. 138(9):811\u2013814. https:\/\/doi.org\/10.1182\/blood.2021012443","journal-title":"Blood."},{"key":"4906_CR32","doi-asserted-by":"publisher","unstructured":"Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, et al. (2021) Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 137: 3165\u201373. N https:\/\/doi.org\/10.1182\/blood.2021011568","DOI":"10.1182\/blood.2021011568"},{"key":"4906_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41375-021-01270-w","volume":"13","author":"LE Roeker","year":"2021","unstructured":"Roeker LE, Knorr DA, Thompson MC, Nivar M, Lebowitz S, Peters N et al (2021 May) COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia. Leukemia. 13:1\u20133. https:\/\/doi.org\/10.1038\/s41375-021-01270-w","journal-title":"Leukemia."},{"issue":"8","key":"4906_CR34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ccell.2021.06.014","volume":"39","author":"O Van Oekelen","year":"2021","unstructured":"Van Oekelen O, Gleason CR, Agte S, Srivastava K, Beach KF, Aleman A et al (2021) Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell 39(8):1028\u20131030. https:\/\/doi.org\/10.1016\/j.ccell.2021.06.014","journal-title":"Cancer Cell"},{"key":"4906_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13045-021-01183-2","volume":"14","author":"S Bitoun","year":"2021","unstructured":"Bitoun S, Henry J, Vauloup-Fellous C, Dib N, Belkhir R, Mouna L et al (2021) Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls. J Hematol Oncol 14:166. https:\/\/doi.org\/10.1186\/s13045-021-01183-2","journal-title":"J Hematol Oncol"},{"key":"4906_CR36","doi-asserted-by":"publisher","unstructured":"Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, et al. (2021) The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment. Blood Cancer J. Aug 2;11(8):138. https:\/\/doi.org\/10.1038\/s41408-021-00530-3. PMID: 34341335; PMCID: PMC8327056.","DOI":"10.1038\/s41408-021-00530-3"},{"key":"4906_CR37","doi-asserted-by":"publisher","unstructured":"Pimpinelli, F., Marchesi, F., Piaggio, G. Giannarelli D, Papa E, Falcucci P, et al. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. J Hematol Oncol 14, 81 (2021). https:\/\/doi.org\/10.1186\/s13045-021-01090-6","DOI":"10.1186\/s13045-021-01090-6"},{"issue":"3","key":"4906_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1182\/bloodadvances.2021006101","volume":"6","author":"M Jim\u00e9nez","year":"2022","unstructured":"Jim\u00e9nez M, Rold\u00e1n E, Fern\u00e1ndez-Naval C, Villacampa G, Martinez-Gallo M, Medina-Gil D et al (2022) Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies. Blood Adv 6(3):774\u2013784. https:\/\/doi.org\/10.1182\/bloodadvances.2021006101","journal-title":"Blood Adv"},{"issue":"1","key":"4906_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-022-01275-7","volume":"15","author":"JL Pi\u00f1ana","year":"2022","unstructured":"Pi\u00f1ana JL, L\u00f3pez-Corral L, Martino R, Vazquez L, P\u00e9rez A, Martin-Martin G et al (2022) Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders. J Hematol Oncol 15(1):54. https:\/\/doi.org\/10.1186\/s13045-022-01275-7","journal-title":"J Hematol Oncol"},{"key":"4906_CR40","doi-asserted-by":"publisher","unstructured":"Aaron Shengting Mai, Ainsley Ryan Yan Bin Lee, Ryan Yong Kiat Tay, Lauren Shapiro, Astha Thakkar, Balazs Halmos, et al. (2022) Booster doses of COVID-19 vaccines for haematological and solid cancer patients: a systematic review and individual patient data meta-analysis. Eur J Cancer. June 02. https:\/\/doi.org\/10.1016\/j.ejca.2022.05.029","DOI":"10.1016\/j.ejca.2022.05.029"},{"issue":"1","key":"4906_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jama.2021.8828","volume":"326","author":"MS Cohen","year":"2021","unstructured":"Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C et al (2021) Effect of Bamlanivimab vs placebo on incidence of COVID-19 among residents and staff of skilled nursing and assisted living facilities: a randomized clinical trial. JAMA. 326(1):46\u201355","journal-title":"JAMA."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04906-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T05:23:52Z","timestamp":1660368232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04906-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["4906"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04906-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"19 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethical committee of the Hospital Cl\u00ednico Universitario of Valencia approved the registry and study protocol (reference code 35.21)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients included in this registry gave their sign informed consent according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The author(s) declare that they have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}